{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:29:14Z","timestamp":1778599754011,"version":"3.51.4"},"reference-count":211,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.cpcardiol.2012.03.002","type":"journal-article","created":{"date-parts":[[2012,6,2]],"date-time":"2012-06-02T18:07:47Z","timestamp":1338660467000},"page":"237-310","source":"Crossref","is-referenced-by-count":19,"title":["Modern Management of Acute Myocardial Infarction"],"prefix":"10.1016","volume":"37","author":[{"given":"Terrence D.","family":"Welch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric H.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy S.","family":"Reeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard J.","family":"Gersh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2012.03.002_bib1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cpcardiol.2006.08.004","article-title":"Modern management of acute myocardial infarction","volume":"31","author":"Yang","year":"2006","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib2","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1161\/01.CIR.0000134791.68010.FA","volume":"110","author":"Antman","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.107.188209","volume":"117","author":"Antman","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib4","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1161\/CIRCULATIONAHA.109.192663","volume":"120","author":"Kushner","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib5","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1161\/CIRCULATIONAHA.107.181940","volume":"116","author":"Anderson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib6","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIR.0b013e31820f2f3e","volume":"123","author":"Wright","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib7","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib8","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0b013e3182009701","article-title":"Heart disease and stroke statistics\u20142011 update: a report from the American Heart Association","volume":"123","author":"Roger","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib9","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa0908610","article-title":"Population trends in the incidence and outcomes of acute myocardial infarction","volume":"362","author":"Yeh","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib10","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(08)60623-6","article-title":"Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data","volume":"371","author":"Xavier","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib11","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM198010163031601","article-title":"Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction","volume":"303","author":"DeWood","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM198608143150703","article-title":"Coronary arteriographic findings soon after non-Q-wave myocardial infarction","volume":"315","author":"DeWood","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib14","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/CIRCULATIONAHA.106.613596","article-title":"Cardiogenic shock: current concepts and improving outcomes","volume":"117","author":"Reynolds","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib15","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1161\/CIRCOUTCOMES.111.961433","article-title":"Impact of prehospital electrocardiogram protocol and immediate catheterization team activation for patients with ST-Elevation-Myocardial infarction","volume":"4","author":"Nestler","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib16","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1161\/CIRCULATIONAHA.108.191098","volume":"119","author":"Wagner","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM199602223340801","article-title":"Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block","volume":"334","author":"Sgarbossa","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib18","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1161\/CIRCULATIONAHA.108.814640","article-title":"Reperfusion injury, microvascular dysfunction, and cardioprotection: the \u201cdark side\u201d of reperfusion","volume":"120","author":"Prasad","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib19","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1161\/CIRCULATIONAHA.107.187397","article-title":"Universal definition of myocardial infarction","volume":"116","author":"Thygesen","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib20","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199610313351802","article-title":"Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes","volume":"335","author":"Antman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib21","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJM199610313351801","article-title":"Cardiac troponin T levels for risk stratification in acute myocardial ischemia","volume":"335","author":"Ohman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2006.02.056","article-title":"Biomarkers in acute cardiac disease: the present and the future","volume":"48","author":"Jaffe","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib23","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1001\/jama.2011.1896","article-title":"Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction","volume":"306","author":"Keller","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0002-9149(67)90023-9","article-title":"Treatment of myocardial infarction in a coronary care unit","volume":"20","author":"Killip","year":"1967","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib25","first-page":"CD007160","article-title":"Oxygen therapy for acute myocardial infarction","author":"Cabello","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib26","first-page":"349","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib28","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/01.CIR.78.4.906","article-title":"Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications","volume":"78","author":"Jugdutt","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib29","first-page":"1115","article-title":"GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9149(96)00217-2","article-title":"Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction","volume":"78","author":"Anderson","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib31","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jama.293.8.979","article-title":"Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?","volume":"293","author":"Gersh","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib32","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMoa013404","article-title":"Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction","volume":"346","author":"Stone","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib33","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJM199311253292204","article-title":"The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","article-title":"Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials","volume":"361","author":"Keeley","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJMoa0706416","article-title":"Thrombus aspiration during primary percutaneous coronary intervention","volume":"358","author":"Svilaas","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib36","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1056\/NEJM199912233412601","article-title":"Coronary angioplasty with or without stent implantation for acute myocardial infarction","volume":"341","author":"Grines","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib37","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMoa0810116","article-title":"Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction","volume":"360","author":"Stone","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib38","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.jacc.2009.03.013","article-title":"Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis","volume":"53","author":"Brar","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0195-668X(02)00468-2","article-title":"Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction","volume":"24","author":"Widimsk\u00fd","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib40","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0735-1097(02)01870-3","article-title":"A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the air primary angioplasty in myocardial infarction study","volume":"39","author":"Grines","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib41","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa025142","article-title":"A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction","volume":"349","author":"Andersen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib42","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1161\/CIRCULATIONAHA.106.638353","article-title":"Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy","volume":"114","author":"Pinto","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib43","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/jama.2010.1139","article-title":"System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention","volume":"304","author":"Terkelsen","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib44","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7326\/0003-4819-155-6-201109200-00004","article-title":"Health care system delay and heart failure in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: follow-up of population-based medical registry data","volume":"155","author":"Terkelsen","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib45","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1001\/jama.298.20.joc70124","article-title":"Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction","volume":"298","author":"Jollis","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib46","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/CIRCULATIONAHA.107.694141","article-title":"A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction","volume":"116","author":"Henry","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib47","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/CIRCULATIONAHA.107.728519","article-title":"Rural interhospital transfer of ST-elevation myocardial infarction patients for percutaneous coronary revascularization: the Stat Heart Program","volume":"117","author":"Aguirre","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib48","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jacc.2010.06.056","article-title":"Door-to-balloon times under 90 min can be routinely achieved for patients transferred for ST-segment elevation myocardial infarction percutaneous coronary intervention in a rural setting","volume":"57","author":"Blankenship","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib49","doi-asserted-by":"crossref","first-page":"389","DOI":"10.7326\/0003-4819-155-6-201109200-00008","article-title":"Reperfusion paradox in ST-segment elevation myocardial infarction","volume":"155","author":"Armstrong","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib50","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCOUTCOMES.110.958421","article-title":"Moving toward improved care for the patient with ST-elevation myocardial infarction: a mandate for systems of care","volume":"3","author":"Henry","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib51","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(94)91161-4","article-title":"Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib52","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(96)02514-7","article-title":"Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour","volume":"348","author":"Boersma","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib53","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib54","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJM199710163371603","article-title":"A comparison of reteplase with alteplase for acute myocardial infarction","volume":"337","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib55","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0140-6736(99)07403-6","article-title":"Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial","volume":"354","author":"Van De Werf","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib56","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMoa050849","article-title":"Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction","volume":"353","author":"Gershlick","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib57","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jacc.2009.03.050","article-title":"Longer-term follow-up of patients recruited to the REACT (rescue angioplasty versus conservative treatment or repeat thrombolysis) trial","volume":"54","author":"Carver","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib58","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(06)68148-8","article-title":"Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials","volume":"367","author":"Keeley","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib59","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.amjcard.2010.11.024","article-title":"Effectiveness and safety of percutaneous coronary intervention after fibrinolytic therapy for ST-segment elevation acute myocardial infarction","volume":"107","author":"Baron","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib60","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0140-6736(04)17059-1","article-title":"Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial","volume":"364","author":"Fernandez-Avil\u00e9s","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib61","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jacc.2009.08.007","volume":"55","author":"B\u00f8hmer","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib62","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1056\/NEJMoa0808276","article-title":"Routine early angioplasty after fibrinolysis for acute myocardial infarction","volume":"360","author":"Cantor","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib63","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehl461","article-title":"Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial","volume":"28","author":"Fern\u00e1ndez-Avil\u00e9s","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib64","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0735-1097(03)00763-0","article-title":"Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction","volume":"42","author":"Scheller","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib65","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0140-6736(08)60268-8","article-title":"Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the combined abciximab reteplase Stent study in acute myocardial infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial","volume":"371","author":"Di Mario","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib66","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/eurheartj\/ehl088","article-title":"A comparison of pharmacologic therapy with\/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (which early ST-elevation myocardial infarction therapy) study","volume":"27","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib67","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1161\/CIRCULATIONAHA.111.018549","article-title":"Benefit of transferring ST-Segment-Elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase","volume":"124","author":"Pinto","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib68","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0140-6736(02)07595-5","article-title":"Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE)","volume":"359","author":"Eagle","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib69","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1001\/jama.293.23.2865","article-title":"Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial","volume":"293","author":"Schomig","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib70","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.amjcard.2010.10.008","article-title":"Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS])","volume":"107","author":"Gierlotka","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib71","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/CIRCULATIONAHA.108.814947","article-title":"Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective","volume":"119","author":"Goldberg","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib72","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic shock","volume":"341","author":"Hochman","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib73","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jcin.2010.06.005","article-title":"Unprotected left main coronary disease and ST-segment elevation myocardial infarction: a contemporary review and argument for percutaneous coronary intervention","volume":"3","author":"Lee","year":"2010","journal-title":"JACC Cardiovasc Intv"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib74","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/eurheartj\/ehm184","article-title":"Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction","volume":"28","author":"Sorajja","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib75","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2011.03.046","article-title":"Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis","volume":"58","author":"Vlaar","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib76","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jacc.2011.02.071","article-title":"Prognostic impact of staged versus \u201cone-time\u201d multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial","volume":"58","author":"Kornowski","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib77","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation","volume":"352","author":"Sabatine","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib78","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","article-title":"Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib79","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/jama.294.10.1224","article-title":"Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study","volume":"294","author":"Sabatine","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib80","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib81","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib82","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1592\/phco.29.12.1441","article-title":"Prasugrel: a critical comparison with clopidogrel","volume":"29","author":"Reinhart","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib83","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jacc.2009.06.021","article-title":"Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial","volume":"54","author":"Dangas","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib84","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJMoa0909475","article-title":"Dose comparisons of clopidogrel and aspirin in acute coronary syndromes","volume":"363","author":"Mehta","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib85","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.jacc.2011.06.044","volume":"58","author":"Patti","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib86","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome p-450 polymorphisms and response to clopidogrel","volume":"360","author":"Mega","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib87","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2010.181","article-title":"Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation","volume":"303","author":"Breet","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib88","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jacc.2010.05.013","volume":"56","author":"Holmes","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib89","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib90","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","article-title":"Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET study","volume":"120","author":"Gurbel","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib91","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib92","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/CIRCULATIONAHA.109.927582","article-title":"Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A platelet inhibition and patient outcomes (PLATO) trial subgroup analysis","volume":"122","author":"Steg","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib93","doi-asserted-by":"crossref","first-page":"d3527","DOI":"10.1136\/bmj.d3527","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient outcomes (PLATO) trial","volume":"342","author":"James","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib94","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCULATIONAHA.111.047498","article-title":"Ticagrelor compared with clopidogrel by geographic region in the platelet inhibition and patient outcomes (PLATO) trial","volume":"124","author":"Mahaffey","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib95","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/01.CIR.101.23.2690","article-title":"High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14","volume":"101","author":"Coulter","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib96","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/jama.293.14.1759","article-title":"Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials","volume":"293","author":"De Luca","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib97","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0735-1097(03)01040-4","article-title":"The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial","volume":"42","author":"Cohen","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib98","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1161\/01.CIR.98.24.2695","article-title":"Effect of glycoprotein IIb\/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction","volume":"98","author":"Neumann","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib99","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1001\/jama.299.15.joc80026","article-title":"Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the multistrategy randomized trial","volume":"299","author":"Valgimigli","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib100","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2009.10.093","article-title":"Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish coronary angiography and angioplasty registry)","volume":"56","author":"Akerblom","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib101","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMoa0706816","article-title":"Facilitated PCI in patients with ST-elevation myocardial infarction","volume":"358","author":"Ellis","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib102","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/j.jacc.2009.11.091","article-title":"Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome","volume":"55","author":"ten Berg","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib103","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0735-1097(92)90296-Y","article-title":"Activation of prothrombin accompanying thrombolysis with recombinant tissue-type plasminogen activator","volume":"19","author":"Eisenberg","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib104","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/hrt.67.2.122","article-title":"Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial","volume":"67","author":"de Bono","year":"1992","journal-title":"Br Heart J"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib105","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1161\/CIRCULATIONAHA.105.573550","article-title":"Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials","volume":"112","author":"Eikelboom","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib106","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/01.CIR.0000139868.53594.24","article-title":"Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention","volume":"110","author":"Brener","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib107","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jama.293.4.427","article-title":"Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation","volume":"293","author":"Yusuf","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib108","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa060898","article-title":"Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction","volume":"354","author":"Antman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib109","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/eurheartj\/ehm224","article-title":"Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis","volume":"28","author":"Murphy","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib110","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.jacc.2007.01.093","article-title":"Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial","volume":"49","author":"Gibson","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib111","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0140-6736(11)60876-3","article-title":"Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial","volume":"378","author":"Montalescot","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib112","first-page":"1855","article-title":"Hirulog and Early Reperfusion or Occlusion (HERO)-2 Trial Investigators","volume":"358","author":"White","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib113","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib114","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0140-6736(11)60764-2","article-title":"Heparin plus a glycoprotein IIb\/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial","volume":"377","author":"Stone","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib115","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jama.295.13.joc60038","article-title":"Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the oasis-6 randomized trial","volume":"295","author":"Yusuf","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib116","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJM199207233270406","article-title":"Cumulative meta-analysis of therapeutic trials for myocardial infarction","volume":"327","author":"Lau","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib117","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"Beta blockade after myocardial infarction: systematic review and meta regression analysis","volume":"318","author":"Freemantle","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib118","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.CIR.83.2.422","article-title":"Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction","volume":"83","author":"Roberts","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib119","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib120","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.jacc.2003.10.068","article-title":"Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction","volume":"43","author":"Halkin","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib121","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.jacc.2003.09.071","article-title":"Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?","volume":"43","author":"Kernis","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib122","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: A guideline from the American Heart Association and American College of Cardiology Foundation","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib123","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jacc.2005.05.086","article-title":"The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes","volume":"46","author":"Ray","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib124","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib125","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib126","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib127","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jacc.2007.02.025","article-title":"Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial","volume":"49","author":"Patti","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib128","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1161\/01.CIR.95.12.2643","article-title":"Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction","volume":"95","author":"Pfeffer","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib129","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(95)90865-X","article-title":"ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0735-1097(95)00498-X","article-title":"Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: the GISSI-3 trial","volume":"27","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib131","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1161\/01.CIR.96.12.4239","article-title":"Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study","volume":"96","author":"Zuanetti","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib132","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib133","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction","volume":"333","author":"K\u00f8ber","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib134","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib135","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1056\/NEJM199209033271002","article-title":"Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction","volume":"327","author":"Swedberg","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib136","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0140-6736(95)90866-8","article-title":"Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: interim report from the Chinese cardiac study (CCS-1)","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib137","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM199501123320203","article-title":"The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction","volume":"332","author":"Ambrosioni","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib138","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","article-title":"Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial","volume":"360","author":"Dickstein","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib139","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib140","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients","volume":"360","author":"Finfer","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib141","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1161\/CIR.0b013e3181dbece1","article-title":"Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association","volume":"121","author":"Brook","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib142","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/eurheartj\/ehq030","article-title":"Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications","volume":"31","author":"Gersh","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib143","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1525-1497.2005.00269.x","article-title":"Prevalence of depression in survivors of acute myocardial infarction","volume":"21","author":"Thombs","year":"2006","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib144","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1161\/01.CIR.102.15.1773","article-title":"Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans","volume":"102","author":"Ariyo","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib145","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archinte.164.3.289","article-title":"Depression and cardiovascular sequelae in postmenopausal women","volume":"164","author":"Wassertheil-Smoller","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib146","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1001\/jama.2008.667","article-title":"Depression screening and patient outcomes in cardiovascular care: a systematic review","volume":"300","author":"Thombs","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib147","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.108.190769","volume":"118","author":"Lichtman","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib148","first-page":"CD001800","article-title":"Exercise-based rehabilitation for coronary heart disease","author":"Jolliffe","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib149","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jacc.2009.01.078","article-title":"Cardiac rehabilitation and survival in older coronary patients","volume":"54","author":"Suaya","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib150","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.110.983536","article-title":"Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community","volume":"123","author":"Goel","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib151","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jacc.2010.09.010","volume":"56","author":"Abraham","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib152","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2010.11.024","article-title":"Clopidogrel-drug interactions","volume":"57","author":"Bates","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib153","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/S0140-6736(09)61751-7","article-title":"Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data","volume":"374","author":"S\u00f8rensen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib154","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archinternmed.2010.271","article-title":"Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation","volume":"170","author":"Hansen","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib155","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib156","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa041489","article-title":"Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction","volume":"351","author":"Hohnloser","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib157","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1056\/NEJMoa0901889","article-title":"Defibrillator implantation early after myocardial infarction","volume":"361","author":"Steinbeck","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib158","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1161\/CIRCUALTIONAHA.108.189742","volume":"117","author":"Epstein","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib159","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: A method for prognostication and therapeutic decision making","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib160","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1001\/archinte.163.19.2345","article-title":"Predictors of hospital mortality in the global registry of acute coronary events","volume":"163","author":"Granger","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib161","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jacc.2005.04.037","article-title":"New risk score for patients with acute chest pain, non-ST-segment deviation, and normal troponin concentrations: a comparison with the TIMI risk score","volume":"46","author":"Sanchis","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib162","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.291.22.2727","article-title":"A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry","volume":"291","author":"Eagle","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib163","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/eurheartj\/ehi187","article-title":"TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS","volume":"26","author":"de Araujo Goncalves","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib164","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/bmj.38985.646481.55","article-title":"Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)","volume":"333","author":"Fox","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib165","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib166","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/01.CIR.0000051362.96946.15","article-title":"Early and late effects of clopidogrel in patients with acute coronary syndromes","volume":"107","author":"Yusuf","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib167","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(02)07442-1","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials","volume":"359","author":"Boersma","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib168","first-page":"1915","article-title":"GUSTO IV-ACS Investigators","volume":"357","author":"Simoons","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib169","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jama.295.13.joc60034","article-title":"Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial","volume":"295","author":"Kastrati","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib170","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/jama.297.6.591","article-title":"Routine upstream initiation vs deferred selective use of glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: the ACUITY timing trial","volume":"297","author":"Stone","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib171","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1056\/NEJMoa0901316","article-title":"Early versus delayed, provisional eptifibatide in acute coronary syndromes","volume":"360","author":"Giugliano","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib172","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0140-6736(00)02324-2","article-title":"Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis","volume":"355","author":"Eikelboom","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib173","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","article-title":"A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease","volume":"337","author":"Cohen","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib174","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/01.CIR.100.15.1593","article-title":"Enoxaparin prevents death and cardiac ischemic events in unstable angina\/non-Q-wave myocardial infarction","volume":"100","author":"Antman","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib175","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jama.292.1.55","article-title":"Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial","volume":"292","author":"Blazing","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib176","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jama.292.1.45","article-title":"Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial","volume":"292","author":"Ferguson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib177","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/jama.292.1.89","article-title":"Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview","volume":"292","author":"Petersen","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib178","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib179","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa055443","article-title":"Comparison of fondaparinux and enoxaparin in acute coronary syndromes","volume":"354","author":"Yusuf","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib180","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.CIR.89.4.1545","article-title":"Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction.Results of the TIMI IIIB trial. Thrombolysis in myocardial ischemia","volume":"89","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib181","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0140-6736(99)07349-3","article-title":"Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib182","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban","volume":"344","author":"Cannon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib183","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(02)09894-X","article-title":"Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction. British Heart Foundation RITA randomised trial. Randomized Intervention Trial of Unstable Angina","volume":"360","author":"Fox","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib184","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1056\/NEJMoa044259","article-title":"Early invasive versus selectively invasive management for acute coronary syndromes","volume":"353","author":"de Winter","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib185","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jacc.2006.06.050","article-title":"Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials","volume":"48","author":"Bavry","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib186","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.jacc.2010.03.007","article-title":"Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data","volume":"55","author":"Fox","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib187","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1056\/NEJMoa0807986","article-title":"Early versus delayed invasive intervention in acute coronary syndromes","volume":"360","author":"Mehta","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib188","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jama.2009.1267","article-title":"Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial","volume":"302","author":"Montalescot","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib189","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.108.838169","volume":"120","author":"Szummer","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib190","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0025-6196(12)65133-7","article-title":"Mechanical and electrical complications of acute myocardial infarction","volume":"65","author":"Lavie","year":"1990","journal-title":"Mayo Clin Proc Mayo Clin"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib191","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0025-6196(12)61116-1","article-title":"Mitral valve operation in postinfarction rupture of a papillary muscle: immediate results and long-term follow-up of 22 patients","volume":"67","author":"Kishon","year":"1992","journal-title":"Mayo Clin Proc Mayo Clin"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib192","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1161\/CIRCULATIONAHA.108.776690","article-title":"Changes in hospital mortality rates in 425 patients with acute ST-elevation myocardial infarction and cardiac rupture over a 30-year period","volume":"118","author":"Figueras","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib193","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/0735-1097(96)00008-3","article-title":"A composite view of cardiac rupture in the united states national registry of myocardial infarction","volume":"27","author":"Becker","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib194","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0735-1097(98)00582-8","article-title":"Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the thrombolysis and thrombin inhibition in myocardial infarction 9 study","volume":"33","author":"Becker","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib195","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0002-8703(89)90617-0","article-title":"Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the multicenter investigation of limitation of infarct size","volume":"117","author":"Pohjola-Sintonen","year":"1989","journal-title":"Am Heart J"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib196","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/0735-1097(93)90182-Z","article-title":"Cardiac rupture, a clinically predictable complication of acute myocardial infarction: report of 70 cases with clinicopathologic correlations","volume":"22","author":"Oliva","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib197","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0735-1097(92)90315-E","article-title":"Diagnosis of subacute ventricular wall rupture after acute myocardial infarction: sensitivity and specificity of clinical, hemodynamic and echocardiographic criteria","volume":"19","author":"L\u00f3pez-Send\u00f3n","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib198","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/01.CIR.101.1.27","article-title":"Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction","volume":"101","author":"Crenshaw","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib199","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-5223(19)36347-0","article-title":"Surgical repair of acquired ventricular septal defect","volume":"93","author":"Jones","year":"1987","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib200","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1043-0679(98)70006-1","article-title":"Transcatheter management of ventricular septal rupture after myocardial infarction","volume":"10","author":"Landzberg","year":"1998","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib201","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1053\/euhj.1997.0857","article-title":"Frequency and prognostic implications of conduction defects in acute myocardial infarction since the introduction of thrombolytic therapy","volume":"19","author":"Archbold","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib202","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9149(03)00900-7","article-title":"Prognostic importance of complete atrioventricular block complicating acute myocardial infarction","volume":"92","author":"Aplin","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib203","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/eurheartj\/ehi622","article-title":"Prognostic differences between different types of bundle branch block during the early phase of acute myocardial infarction: insights from the hirulog and early reperfusion or occlusion (HERO)-2 trial","volume":"27","author":"Wong","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib204","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurheartj\/ehn579","article-title":"Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications","volume":"30","author":"Schmitt","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib205","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1067\/mhj.2000.111108","article-title":"New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience","volume":"140","author":"Wong","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib206","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/eurheartj\/ehi064","article-title":"Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience","volume":"26","author":"Lehto","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib207","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0002-9149(88)90921-6","article-title":"Usefulness of the accelerated idioventricular rhythm as a marker for myocardial necrosis and reperfusion during thrombolytic therapy in acute myocardial infarction","volume":"61","author":"Gorgels","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib208","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCULATIONAHA.110.937136","volume":"122","author":"Scirica","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib209","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1161\/01.CIR.98.23.2567","article-title":"Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes","volume":"98","author":"Newby","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib210","doi-asserted-by":"crossref","first-page":"S729","DOI":"10.1161\/CIRCULATIONAHA.110.970988","article-title":"Part 8: Adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care","volume":"122","author":"Neumar","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2012.03.002_bib211","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/CIRCOUTCOMES.109.919415","article-title":"Optimal medical therapy for non-ST-segment-elevation acute coronary syndromes: exploring why physicians do not prescribe evidence-based treatment and why patients discontinue medications after discharge","volume":"3","author":"Bagnall","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280612000370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280612000370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T09:32:55Z","timestamp":1594200775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280612000370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":211,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0146280612000370"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2012.03.002","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}